[17 May 2013]
Products Affected - Description
Bupivacaine 0.25%
Sensorcaine 0.25%, APP
30 mL vial, preservative-free (NDC 63323-0464-37)
Bupivacaine 0.25% injection, Hospira
10 mL vial, preservative-free (NDC 00409-1159-01)
50 mL vial, multi-dose (NDC 00409-1160-01)
Marcaine 0.25% injection, Hospira
30 mL vial, preservative-free (NDC 00409-1559-30)
Bupivacaine 0.5%
Bupivacaine 0.5%, Hospira
10 mL vial, preservative-free (NDC 00409-1162-01)
30 mL vial, preservative-free (NDC 00409-1162-02)
50 mL vial, multi-dose (NDC 00409- 1163-01)
Marcaine 0.5%, Hospira
10 mL vial, preservative-free (NDC 00409-1560-10)
30 mL vial, preservative-free (NDC 00409-1560-29)
Sensorcaine 0.5%, APP
30 mL vial, preservative-free, sterile pack (NDC 63323-0466-31)
30 mL vial, preservative-free (NDC 63323- 0466-37)
Bupivacaine 0.75%
Bupivacaine 0.75%, Hospira
30 mL vial, preservative-free (NDC 00409-1165-02)
Reason for the Shortage
- APP has Sensorcaine on shortage due to increased demand for the product.
- Hospira has bupivacaine and Marcaine on shortage due to manufacturing delays.
Available Products
Bupivacaine 0.25%
Sensorcaine 0.25%, APP
10 mL vial, preservative-free (NDC 63323-0464-17)
30 mL vial, preservative-free, sterile pack (NDC 63323-0464-31)
50 mL vial, multi-dose (NDC 63323-0465-57)
Bupivacaine 0.25% injection, Hospira
20 mL glass ampule, sterile pack (NDC 00409-4272-01)
30 mL glass ampule (NDC 00409-1158-01)
30 mL vial, preservative-free (NDC 00409-1159-02)
Marcaine 0.25% injection, Hospira
10 mL vial, preservative-free (NDC 00409-1559-10)
50 mL vial, multi-dose (NDC 00409-1587-50)
Bupivacaine 0.5%
Sensorcaine 0.5%, APP
10 mL vial, preservative-free (NDC 63323- 0466-17)
50 mL vial, multi-dose (NDC 63323-0467-57)
Bupivacaine 0.5%, Hospira
20 mL glass ampule, sterile pack (NDC 00409-4273-01)
30 mL glass ampule (NDC 00409-1161-01)
Marcaine 0.5%, Hospira
50 mL vial, multi-dose (NDC 00409-1610-50)
Bupivacaine 0.75%
Sensorcaine 0.75%, APP
10 mL vial, preservative-free (NDC 63323-0472-17)
30 mL vial, preservative-free (NDC 63323-0472-37)
Bupivacaine 0.75%, Hospira
10 mL vial, preservative-free (NDC 00409-1165-01)
Marcaine 0.75%, Hospira
10 mL vial, preservative-free (NDC 00409-1582-10)
30 mL vial, preservative-free (NDC 00409-1582-29)
Estimated Resupply Dates
Bupivacaine 0.25%
- Hospira has bupivacaine 0.25% 50 mL vials on back order and the company estimates a release date of June 2013. Bupivacaine 0.25% 10 mL are on back order with an estimated release date of May 2013.
- Hospira has Marcaine 0.25% 30 mL preservative-free vials on allocation.
- APP has Sensorcaine 0.25% 30 mL preservative-free vials on back order and the company estimates a release date in mid-May 2013.
Bupivacaine 0.5%
- Hospira has bupivacaine 0.5% 10 mL preservative-free vials and 50 mL vial are on back order and the company estimates a release date in July 2013. Bupivacaine 0.5% 30 mL preservative-free vials are on back order and the company estimates a release date of late-May 2013.
- Hospira has Marcaine 0.5% 10 mL preservative free vials on back order with an estimated release date in May. Marcaine 0.5% 30 mL preservative-free vials are on back order with an estimated release date of June 2013.
- APP has Sensorcaine 0.5% 30 mL preservative-free vials on back order and the company estimates a release date of mid- to late-May 2013. Sensorcaine 0.5% 30 mL preservative-free sterile pack vials are on back order and the company estimates a release date of mid-May 2013.
Bupivacaine 0.75%
- Hospira has bupivacaine 0.75% 30 mL vials on back order and the company estimates a release date of May 2013.
Related Shortages
Updated
May 17, 2013; May 10, 2013; April 4, 2013; March 13, 2013; March 5, 2013; February 7, 2013; January 17, 2013; December 12, 2012; November 9, 2012; October 22, 2012; September 19, 2012; August 22, 2012; August 9, 2012; July 10, 2012; June 18, 2012; May 17, 2012; April 16, 2012; March 27, 2012; March 7, 2012; February 22, 2012; February 8, 2012; January 25, 2012; January 5, 2012; December 21, 2011; December 7, 2011; November 21, 2011; November 16, 2011; University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.
Disclaimer
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins